Twist Bioscience (TWST) News Today → Next President (Not Trump. Not Biden.) (From The Freeport Society) (Ad) Free TWST Stock Alerts $47.01 +0.51 (+1.10%) (As of 05/17/2024 08:54 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 17 at 8:59 PM | marketbeat.comNikko Asset Management Americas Inc. Boosts Stake in Twist Bioscience Co. (NASDAQ:TWST)Nikko Asset Management Americas Inc. boosted its stake in Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 2.9% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 3,583,443 shares of the company's stock after buying an adMay 13, 2024 | msn.comTwist Bioscience launches MGF product, stock climbs 10%May 13, 2024 | marketbeat.comTwist Bioscience (NASDAQ:TWST) Sets New 52-Week High at $45.12Twist Bioscience (NASDAQ:TWST) Reaches New 12-Month High at $45.12May 13, 2024 | businesswire.comTwist Bioscience Launches Multiplexed Gene Fragments to Enable High-throughput Screening ApplicationsMay 13, 2024 | marketbeat.comNational Bank of Canada FI Buys 79,400 Shares of Twist Bioscience Co. (NASDAQ:TWST)National Bank of Canada FI increased its position in Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 264,666.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 79,430 shares of the coMay 8, 2024 | businesswire.comTwist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)May 8, 2024 | insidertrades.comTwist Bioscience Co. (NASDAQ:TWST) Insider William Banyai Sells 798 Shares of StockMay 7, 2024 | marketbeat.comTwist Bioscience Co. (NASDAQ:TWST) Insider Sells $29,629.74 in StockTwist Bioscience Co. (NASDAQ:TWST - Get Free Report) insider William Banyai sold 798 shares of the stock in a transaction that occurred on Friday, May 3rd. The stock was sold at an average price of $37.13, for a total transaction of $29,629.74. Following the completion of the sale, the insider now directly owns 345,188 shares of the company's stock, valued at $12,816,830.44. The transaction was disclosed in a filing with the SEC, which is available at this link.May 6, 2024 | markets.businessinsider.comBreaking Down Twist Bioscience: 5 Analysts Share Their ViewsMay 6, 2024 | marketbeat.comTwist Bioscience (NASDAQ:TWST) Hits New 1-Year High Following Analyst UpgradeTwist Bioscience (NASDAQ:TWST) Hits New 1-Year High After Analyst UpgradeMay 4, 2024 | finance.yahoo.comEarnings Update: Twist Bioscience Corporation (NASDAQ:TWST) Just Reported Its Second-Quarter Results And Analysts Are Updating Their ForecastsMay 4, 2024 | marketbeat.com123,447 Shares in Twist Bioscience Co. (NASDAQ:TWST) Purchased by Vestmark Advisory Solutions Inc.Vestmark Advisory Solutions Inc. purchased a new position in shares of Twist Bioscience Co. (NASDAQ:TWST - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 123,447 shares of the company's stock, valued at appMay 3, 2024 | marketbeat.comTwist Bioscience (NASDAQ:TWST) Posts Earnings Results, Beats Expectations By $0.05 EPSTwist Bioscience (NASDAQ:TWST - Get Free Report) announced its earnings results on Thursday. The company reported ($0.79) earnings per share for the quarter, beating analysts' consensus estimates of ($0.84) by $0.05. The company had revenue of $75.30 million during the quarter, compared to analyst estimates of $70.70 million. Twist Bioscience had a negative return on equity of 32.16% and a negative net margin of 78.44%. The firm's quarterly revenue was up 25.1% compared to the same quarter last year. During the same period last year, the company posted ($1.06) earnings per share.May 3, 2024 | marketwatch.comTwist Biosciences Shares Rise 25% on Narrower-Than-Expected 2Q LossMay 3, 2024 | markets.businessinsider.comGenomics firm Twist Bioscience's Momentum To Continue Throughout 2024, Analyst SaysMay 3, 2024 | marketbeat.comEvercore ISI Raises Twist Bioscience (NASDAQ:TWST) Price Target to $50.00Evercore ISI boosted their price objective on shares of Twist Bioscience from $46.00 to $50.00 and gave the company an "outperform" rating in a report on Friday.May 3, 2024 | marketbeat.comTwist Bioscience Co. (NASDAQ:TWST) Receives Average Rating of "Buy" from AnalystsTwist Bioscience Co. (NASDAQ:TWST - Get Free Report) has been assigned an average recommendation of "Buy" from the six research firms that are covering the stock, MarketBeat Ratings reports. Six analysts have rated the stock with a buy rating. The average 12-month price target among analysts thatMay 3, 2024 | seekingalpha.comTwist Bioscience: NGS Is Taking OffMay 3, 2024 | marketbeat.comTwist Bioscience (NASDAQ:TWST) Shares Gap Up Following Earnings BeatTwist Bioscience (NASDAQ:TWST) Shares Gap Up on Better-Than-Expected EarningsMay 3, 2024 | finance.yahoo.comQ2 2024 Twist Bioscience Corp Earnings CallMay 3, 2024 | finance.yahoo.comTwist Bioscience Corporation (NASDAQ:TWST) Q2 2024 Earnings Call TranscriptMay 2, 2024 | investorplace.comTWST Stock Earnings: Twist Bioscience Beats EPS, Beats Revenue for Q2 2024May 2, 2024 | markets.businessinsider.comTwist Bioscience: Strong Demand and Strategic Positioning Fuel Buy RatingMay 2, 2024 | sfgate.comTwist Bioscience: Fiscal Q2 Earnings SnapshotMay 2, 2024 | businesswire.comTwist Bioscience Reports Fiscal Second Quarter 2024 Financial ResultsMay 1, 2024 | markets.businessinsider.comTwist Bioscience is about to announce its earnings — here's what Wall Street expectsApril 30, 2024 | investorplace.com3 Biotech Stocks with Blockbuster Drug Pipelines: April EditionApril 26, 2024 | insidertrades.comTwist Bioscience Co. (NASDAQ:TWST) COO Patrick John Finn Sells 2,174 SharesApril 25, 2024 | marketbeat.comTwist Bioscience Co. (NASDAQ:TWST) COO Sells $65,480.88 in StockTwist Bioscience Co. (NASDAQ:TWST - Get Free Report) COO Patrick John Finn sold 2,174 shares of the firm's stock in a transaction on Tuesday, April 23rd. The stock was sold at an average price of $30.12, for a total value of $65,480.88. Following the transaction, the chief operating officer now owns 176,206 shares of the company's stock, valued at $5,307,324.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.April 23, 2024 | marketbeat.comTwist Bioscience (NASDAQ:TWST) Stock Price Up 8%Twist Bioscience (NASDAQ:TWST) Stock Price Up 8%April 21, 2024 | marketbeat.com62,295 Shares in Twist Bioscience Co. (NASDAQ:TWST) Acquired by Knights of Columbus Asset Advisors LLCKnights of Columbus Asset Advisors LLC purchased a new position in shares of Twist Bioscience Co. (NASDAQ:TWST - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 62,295 shares of the company's stock, valued at appApril 18, 2024 | businesswire.comTwist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024April 16, 2024 | marketbeat.comTwist Bioscience (NASDAQ:TWST) Stock Price Down 4.4%Twist Bioscience (NASDAQ:TWST) Stock Price Down 4.4%April 16, 2024 | marketbeat.comSumitomo Mitsui Trust Holdings Inc. Purchases 99,511 Shares of Twist Bioscience Co. (NASDAQ:TWST)Sumitomo Mitsui Trust Holdings Inc. lifted its stake in shares of Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 2.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 3,583,443 shares of the company's stock afterApril 14, 2024 | investing.comCathie Wood’s ARK ETFs buy Roku, Twist Bioscience stockApril 13, 2024 | investing.comTwist Bioscience CFO sells shares to cover taxesApril 12, 2024 | morningstar.comTwist Bioscience Corp TWSTApril 12, 2024 | finance.yahoo.comTwist Bioscience Corporation (TWST)April 12, 2024 | insidertrades.comInsider Selling: Twist Bioscience Co. (NASDAQ:TWST) CFO Sells 556 Shares of StockApril 10, 2024 | markets.businessinsider.comAnalyst Scoreboard: 5 Ratings For Twist BioscienceApril 10, 2024 | marketbeat.comTwist Bioscience (NASDAQ:TWST) Price Target Lowered to $40.00 at BarclaysBarclays reduced their target price on shares of Twist Bioscience from $45.00 to $40.00 and set an "overweight" rating on the stock in a research report on Wednesday.April 10, 2024 | marketbeat.comTwist Bioscience (NASDAQ:TWST) Shares Gap Down to $33.73Twist Bioscience (NASDAQ:TWST) Shares Gap Down to $33.73April 10, 2024 | marketbeat.comTwist Bioscience Co. (NASDAQ:TWST) Shares Sold by Baillie Gifford & Co.Baillie Gifford & Co. cut its holdings in shares of Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 13.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,094,758 shares of the company's stock after sellingApril 6, 2024 | investing.comTwist Bioscience exec sells shares to cover tax withholdingApril 5, 2024 | insidertrades.comTwist Bioscience Co. (NASDAQ:TWST) Insider William Banyai Sells 327 SharesApril 5, 2024 | insidertrades.comInsider Selling: Twist Bioscience Co. (NASDAQ:TWST) COO Sells 492 Shares of StockApril 4, 2024 | marketbeat.comVanguard Group Inc. Decreases Stock Holdings in Twist Bioscience Co. (NASDAQ:TWST)Vanguard Group Inc. decreased its stake in shares of Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 5.0% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,590,974 shares of the company's stock aApril 3, 2024 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Atossa Therapeutics (ATOS), Arbutus Biopharma (ABUS)March 28, 2024 | businesswire.comTwist Bioscience Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse PopulationsMarch 28, 2024 | marketbeat.comARK Investment Management LLC Buys 427,274 Shares of Twist Bioscience Co. (NASDAQ:TWST)ARK Investment Management LLC raised its stake in shares of Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 6.3% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 7,213,257 shares of the company's stock after purchasing an additional 427,274 shares during Get Twist Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for TWST and its competitors with MarketBeat's FREE daily newsletter. Email Address Shocking $16T Elon Musk Crypto Leak (Ad)Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run. Click here now to get your copy. TWST Media Mentions By Week TWST Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TWST News Sentiment▼0.740.42▲Average Medical News Sentiment TWST News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TWST Articles This Week▼53▲TWST Articles Average Week Get Twist Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for TWST and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Immunocore News Arcellx News Denali Therapeutics News Iovance Biotherapeutics News SpringWorks Therapeutics News Vericel News Recursion Pharmaceuticals News Apogee Therapeutics News Kymera Therapeutics News ADMA Biologics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TWST) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaNext President (Not Trump. Not Biden.)The Freeport SocietyUrgent Nvidia WarningAltimetryElon’s New Device is About to Shock the WorldInvestorPlace"The Biggest Drug Ever" Is ComingBehind the MarketsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Twist Bioscience Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
